| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |